Dietary fat, fatty acids and breast cancer

Breast Cancer

Volumn 4, Issue 1, 1997, Pages 7-16

  Rose, David P ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

Breast cancer; Diet; Eicosanoids; Fatty acids; Prevention

Indexed keywords

EID: 0002528128     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02967049     Document Type: Review

References (99)

1. Willed WC, Hunter DJ, Stampfer MJ, et al: Dietary fat and fiber in relation to risk of breast cancer; An 8-year follow-up. JAMA 268:2037-2044, 1992.
2. Boyd NF: Nutrition and breast cancer. J Natl Cancer Inst 85:6-7, 1993. (Pubitemid 23023210)
3. Whittemore AS, Henderson BE: Dietary fat and breast cancer; Where are we? J Natl Cancer Inst 85:762-763, 1993. (Pubitemid 23150299)
4. Freedman LS, Prentice RL, Clifford C, et al: Dietary fat and breast cancer; Where we are. J Natl Cancer Inst 85:764-765, 1993. (Pubitemid 23150300)
5. Cohen LA: Dietary fat and mammary cancer. In: Reddy BS, Cohen LA eds, Diet, Nutrition and Cancer Vol I, CRC Press, Boca Raton, pp77-100, 1986.
6. Slattery ML, O'Brien E, Mori M: Disease heterogeneity; Does it impact our ability to detect dietary associations with breast cancer? Nutr Cancer 24:213-220, 1995.
7. Chlebowski RT, Rose DP, Buzzard IM, et al: Adjuvant dietary fat intake reduction in postmenopausal breast cancer patient management. Breast Cancer Res Treat 20:73-84, 1991.
8. Armstrong B, Doll R: Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 15:617-631, 1975.
9. Hems G: The contributions of diet and childbearing to breast cancer rates. Br J Cancer 37:974-982, 1978. (Pubitemid 8367560)
10. Rose DP, Boyar AP, Wynder EL: International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer 58:2363-2371, 1986. (Pubitemid 17191592)
11. Prentice RL, Sheppard L: Dietary fat and cancer; Consistency of the epidemiologic data, and disease prevention that may follow from a practical reduction in fat consumption. Cancer Causes Control 1:81-97, 1990.
12. Sasaki S, Horacsek M, Kesteloot H: An ecological study of the relationship between dietary fat intake and breast cancer mortality. Prev Med 22:187-202, 1993. (Pubitemid 23150663)
13. Hirayama T: Epidemiology of breast cancer with special reference to the role of diet. Prev Med 7:173-195, 1978. (Pubitemid 8345602)
14. Howe GR, Friedenreich CM, Jain M, et al: A cohort study of fat intake and risk of breast cancer. J Natl Cancer Inst 83:336-340, 1991.
15. Hunter DJ, Spiegelman D, Adami H-O, et al: Cohort studies of fat intake and the risk of breast cancer; A pooled analysis. N Engl J Med 334:356-361, 1996. (Pubitemid 26049588)
16. Tominaga S, Kuroishi T: Epidemiology of breast cancer in Japan. Cancer Lett 90:75-79, 1995.
17. Tsukuma H, Kitagawa T, Hanai A, et al: Future prediction in cancer incidence in Japan. In: Tominaga S, Aoki K, Hanai A, Kurihara M eds, Gann Tokei Hakusho - Rikan/Sibou/Yogo - 1993, Shinohara Shuppan, Tokyo, pp153-170, 1993.
18. Kato I, Tominaga S, Kuroishi T: Relationship between westernization of dietary habits and mortality from breast and ovarian cancers in Japan. Jpn J Cancer Res 78:349-357, 1987. (Pubitemid 17102279)
19. Minami Y, Takano A, Okuno Y, et al: Trends in the incidence of female breast and cervical cancers in Miyagi Prefecture, Japan, 1959-1987. Jpn J Cancer Res 87:10-17, 1996. (Pubitemid 26062843)
20. Rose DP: Diet, hormones, and cancer. Annu Rev Publ Health 14:1-17, 1993. (Pubitemid 23161709)
21. Shimizu H, Ross RK, Bernstein L, et al: Serum oestrogen levels in postmenopausal women; Comparison of American whites and Japanese in Japan. Br J Cancer 62:451-453, 1990. (Pubitemid 20292845)
22. Bulbrook RD, Swain MC, Wang DY, et al: Breast cancer in Britain and Japan; Plasma oestradiol-17α, oestrone and progesterone, and their urinary metabolites in normal British and Japanese women. Eur J Cancer 12:725-735, 1976.
23. Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146-151, 1985. (Pubitemid 15192861)
24. Carter CL, Carle DK, Micozzi MS, et al: A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 128:467-477, 1988.
25. Nomura Y, Tashiro H, Katsuda Y: Benign breast disease as a breast cancer risk in Japanese women. Jpn J Cancer Res 84:938-944, 1993. (Pubitemid 23280227)
26. Lubin F, Wax Y, Ron E, et al: Nutritional factors associated with benign breast disease etiology; A casecontrol study. Am J Clin Nutr 50:551-556, 1989.
27. Hislop TG, Band PR, Deschamps M, et al: Diet and histologic types of benign breast disease defined by subsequent risk of breast cancer. Am J Epidemiol 131:263-270, 1990.
28. Wynder EL, Fujita Y, Harris RE, et al: Comparative epidemiology of cancer between the United States and Japan; A second look. Cancer 67:746-763, 1991.
29. Schnitt SJ, Jimi A, Kojiro M: The increasing prevalence of benign proliferative breast lesions in Japanese women. Cancer 71:2528-2531, 1993. (Pubitemid 23100487)
30. Carlile T, Kopecky KT, Thompson DJ, et al: Breast cancer prediction and Wolfe classification of mammograms. JAMA 254:1050-1053, 1985. (Pubitemid 15012825)
31. Goodwin PJ, Boyd NF: Mammographic parenchymal pattern and breast cancer risk; A critical appraisal of the evidence. Am J Epidemiol 127:1097-1108, 1988.
32. Gravelle IH, Bulstrode JC, Bulbrook RD, et al: A prospective study of mammographic parenchymal patterns and risk of breast cancer. Br J Radiol 59:487-491, 1986. (Pubitemid 16078671)
33. Gravelle IH, Bulbrook RD, Wang DY, et al: A comparison of mammographic parenchymal patterns in premenopausal Japanese and British women. Breast Cancer Res Treat 18:S93-S95, 1991.
34. Brisson J, Verreault R, Morrison AS, et al: Diet, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 130:14-24, 1989. (Pubitemid 19179382)
35. Nordevang E, Azavedo E, Svane G, et al: Dietary habits and mammographic patterns in patients with breast cancer. Breast Cancer Res Treat 26:207-215, 1993. (Pubitemid 23304236)
36. Cohen LA, Rose DP, Wynder EL: A rationale for dietary intervention in postmenopausal breast cancer patients; An update. Nutr Cancer 19:1-10, 1993. (Pubitemid 23073386)
37. Holm LE, Nordevang E, Hjalmar ML, et al: Treatment failure and dietary habits in women with breast cancer. J Natl Cancer Inst 85:32-36, 1993. (Pubitemid 23023220)
38. Rohan TE, Hiller JE, McMichael AJ: Dietary factors and survival from breast cancer. Nutr Cancer 20:167-177, 1993. (Pubitemid 23270885)
39. Wynder EL, Kajitani T, Kuno J, et al: A comparison of survival rates between American and Japanese patients with breast cancer. Surg Gynecol Obstet 117:196-200, 1963.
40. Morrison AS, Lowe CR, MacMahon B, et al: Some international differences in treatment and survival in breast cancer. Int J Cancer 18:269-273, 1976.
41. Sakamoto G, Sugano H, Hartman WH: Stage-bystage survival from breast cancer in the U. S. and Japan. Jpn J Cancer 25:161-170, 1979.
42. Allen DS, Bulbrook RD, Chaudary MA, et al: Recurrence and survival rates in British and Japanese women with breast cancer. Breast Cancer Res Treat 18:S131-S134, 1991.
43. Le Marchand L, Kolonel LN, Nomura AMY: Breast cancer survival among Hawaii Japanese and Caucasian women; Ten-year rates and survival by place of birth. Am J Epidemiol 122:571-578, 1985. (Pubitemid 15023232)
44. Nomura AMY, Le Marchand L, Kolonel LN, et al: The effect of dietary fat on breast cancer survival among Caucasian and Japanese women in Hawaii. Breast Cancer Res Treat 18:S135-S141, 1991.
45. Kolonel LN, Hankin JL, Lee J, et al: Nutrient intakes in relation to cancer incidence in Hawaii. Br J Cancer 44:332-339, 1981. (Pubitemid 11007271)
46. Hankin JH, Kolonel LN, Yano K, et al: Epidemiology of diet-related diseases in the Japanese migrant population of Hawaii. Proc Nutr Soc Aust 8:22-40, 1983.
47. Kakar F, Henderson M: Diet and breast cancer. Clin Nutr 4:119-130, 1985.
48. Wynder EL, Rose DP, Cohen LA: Diet and breast cancer in causation and therapy. Cancer 58:1804-1813, 1986. (Pubitemid 16008747)
49. Kamano, K, Okuyama H, Konishi R, et al: Effects of a high-linoleate and a high-α-linolenate diet on spontaneous mammary tumorigenesis in mice. Anticancer Res 9:1903-1908, 1989. (Pubitemid 20082186)
50. Lands WEM, Hamazaki T, Yamazaki K, et al: Changing dietary patterns. Am J Clin Nutr 51:991-993, 1990.
51. Goto Y: Changing trends in dietary habits and cardiovascular disease in Japan; An overview. Nutr Rev 50:398-401, 1992. (Pubitemid 23056465)
52. Knazek RA, Liu SC, Bodwin JS, et al: Requirement of essential fatty acids in the diet for development of the mouse mammary gland. J Natl Cancer Inst 64:377-382, 1980.
53. Miyamoto-Tiaven MJ, Hillyard LA, Abraham S: Influence of dietary fat on the growth of mammary ducts in BALB/C mice. J Natl Cancer Inst 67:179-188, 1981. (Pubitemid 11087569)
54. 2. J Biol Chem 263:7567-7573, 1988.
55. Cohen LA, Thompson DO, Choi K, et al: Dietary fat and mammary cancer, II; Modulation of the serum and tumor lipid composition and tumor prostaglandins by different dietary fats; Association with tumor incidence patterns. J Natl Cancer Inst 77:43-51, 1986. (Pubitemid 16061780)
56. Carter CA, Milholland RJ, Shea W, et al: Effect of the prostaglandin synthetase inhibitor indomethacin on 7,12 - dimethylbenz (a) anthracene - induced mammary tumorigenesis in rats fed different levels of fat. Cancer Res 43:3559-3569, 1983.
57. Abou-El-Ela SH, Prasse KW, Carroll R, et al: Eicosanoid synthesis in 7,12-dimethylbenz (a) anthracene-induced mammary carcinomas in Sprague-Dawley rats fed primrose oil, menhaden oil or corn oil. Lipids 23:948-954, 1988.
58. Abou-El-Ela SH, Prasse KW, Farrell RL, et al: Effects of D, L-2-difluoromethylornithine and indomethacin on mammary tumor promotion in rats fed high n-3 and/or n-6 fat diets. Cancer Res 49:1434-1440, 1989. (Pubitemid 19088678)
59. Noguchi M, Kitagawa H, Miyazaki I, et al: Influence of esculetin on incidence, proliferation, and cell kinetics of mammary carcinomas induced by 7,12-dimethylbenz (a) anthracene in rats on high-and lowfat diets. Jpn J Cancer Res 84:1010-1014, 1993. (Pubitemid 23307833)
60. Kitagawa H, Noguchi M: Comparative effects of piroxicam and esculetin on incidence, proliferation, and cell kinetics of mammary carcinomas induced by 7,12-dimethylbenz [a] anthracene in rats on high-and low-fat diets. Oncology 51:401-410, 1994. (Pubitemid 24255304)
61. Rose DP, Connolly JM: Effects of fatty acids and inhibitors of eicosanoid synthesis on the growth of a human breast cancer cell line in culture. Cancer Res 50:7139-7144, 1990.
62. Buckman DK, Hubbard NE, Erickson KL: Eicosanoids and linoleate-enhanced growth of mouse mammary tumor cells. Prostaglandins Leukot Essent Fatty Acids 44:177-184, 1991.
63. Earashi M, Noguchi M, Kinoshita K, et al: Effects of eicosanoid synthesis inhibitors on the in vitro growth and prostaglandin E and leukotriene B secretion of a human breast cancer cell line. Oncology 52:150-155, 1995.
64. Rose DP, Connolly JM, Liu X-H: Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice, and the invasive capacity of these cell lines in vitro. Cancer Res 54:6557-6562, 1994.
65. Meschter CL, Connolly JM, Rose DP: Influence of regional location of the inoculation site, and dietary fat on the pathology of MDA-MB-435 human breast cancer cell-derived tumors in nude mice. Clin Exp Metastasis 10:167-173, 1992.
66. Rose DP, Connolly JM, Meschter CL: Effect of dietary fat on human breast cancer growth and lung metastasis in nude mice. J Natl Cancer Inst 83:1491-1495, 1991.
67. Rose DP, Hatala MA, Connolly JM, et al: Effect of diets containing different levels of linoleic acid on human breast cancer growth and lung metastasis in nude mice. Cancer Res 53:4686-4690, 1993. (Pubitemid 23304401)
68. Rose DP, Connolly JM: Effects of dietary omega-3 fatty acids on human breast cancer growth and metastasis in nude mice. J Natl Cancer Inst 85:1743-1747, 1993. (Pubitemid 23320844)
69. Rose DP, Connolly JM, Rayburn J, et al: Influence of diets containing different levels of eicosapentaenoic or docosahexaenoic acid on the growth and metastasis of human breast cancer cells in nude mice. J Natl Cancer Inst 87:587-592, 1995.
70. Rose DP, Connolly JM, Coleman M: Effect of omega-3 fatty acids on the progression of metastases after the surgical excision of human breast cancer cell solid tumors growing in nude mice. Clin Cancer Res 2:1751-1756, 1996. (Pubitemid 26356361)
71. Kinoshita K, Noguchi M, Earashi M, et al: Inhibitory effects of purified eicosapentaenoic acid and docosahexaenoic acid on growth and metastasis of murine transplantable mammary tumor. In Vivo 8:371-374, 1994. (Pubitemid 24269712)
72. Tamura Y, Hirai A, Terano T, et al: Clinical and epidemiological studies of ω-3 polyunsaturated fatty acids in Japan. In: Tanaka T, Okada A eds, Nutritional Support in Organ Failure, Elsevier, New York, pp89-95, 1990. (Pubitemid 20166351)
73. Kaizer L, Boyd NF, Kriukov V, et al: Fish consumption and breast cancer risk; An ecological study. Nutr Cancer 12:61-68, 1989. (Pubitemid 19055768)
74. Lanier AP, Kelly JJ, Smith B, et al: Alaska Native cancer update; Incidence rates 1989-1993. Cancer Epidemiol Biomarkers Prev 5:749-751, 1996. (Pubitemid 26304650)
75. Hebert JR, Rosen A: Nutritional, socioeconomic, and reproductive factors in relation to female breast cancer mortality; Findings from a cross-national study. Cancer Detect Prevent 20:234-244, 1996.
76. Rose DP: Dietary fatty acids and cancer. Am J Clin Nutr, In press.
77. Stracke ML, Liotta LA: Multi-step cascade of tumor cell metastasis. In Vivo 6:309-316, 1992.
78. Kohn E: Aging issues in invasion and metastasis. Cancer 71:552-557, 1993.
79. Connolly JM, Rose DP: Effects of fatty acids on invasion through reconstituted basement membrane ("Matrigel") by a human breast cancer cell line. Cancer Lett 75:137-142, 1993. (Pubitemid 24014537)
80. Palmantier R, Roberts JD, Glasgow WC, et al: Regulation of the adhesion of a human breast carcinoma cell line to type IV collagen and vitronectin; Roles for lipoxygenase and protein kinase C. Cancer Res 56:2206-2212, 1996. (Pubitemid 26119926)
81. Liu X-H, Rose, DP: Stimulation of type IV collagenase expression by linoleic acid in a metastatic human breast cancer cell line. Cancer Lett 76:71-77, 1994. (Pubitemid 24051650)
82. Liu X-H, Connolly JM, Rose DP: Eicosanoids as mediators of linoleic acid-stimulated invasion and type IV collagenase production by a metastatic human breast cancer cell line. Clin Exp Metastasis 14:145-152, 1996. (Pubitemid 26074277)
83. Liu X-H, Rose DP: Suppression of type IV collagenase in MDA-MB-435 human breast cancer cells by eicosapentaenoic acid in vitro and in vivo. Cancer Lett 92:21-26, 1995.
84. Chen YQ, Duniec ZM, Liu B, et al: Endogenous 12 (S) - HETE production by tumor cells and its role in metastasis. Cancer Res 54:1574-1579, 1994. (Pubitemid 24106425)
85. Miller FR, Heppner GH: Cellular interactions in metastasis. Cancer Metastasis Rev 9:21-34, 1990. (Pubitemid 20237641)
86. Rolland PH, Martin PM, Jacquemier AM, et al: Prostaglandin in human breast cancer; Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J Natl Cancer Inst 64:1061-1070, 1980. (Pubitemid 10100318)
87. Fulton AM, Heppner GH: Relationships of prostaglandin E and natural killer sensitivity to metastatic potential in murine mammary adenocarcinomas. Cancer Res 45:4779-4784, 1985. (Pubitemid 16236148)
88. Hubbard NE, Chapkin RS, Erickson KL: Inhibition of growth and linoleate-enhanced metastasis of a transplantable mouse mammary tumor by indomethacin. Cancer Lett 43:111-120, 1988. (Pubitemid 19006405)
89. Fontán PA, Amura CR, Sordelli DO: Treatment with a non-steroidal anti-inflammatory agent delays the growth of spontaneous pulmonary metastases of a mammary adenocarcinoma of non-detected immunogenicity. Br J Cancer 66:800-804, 1992.
90. Lala PK, Parhar RS: Eradication of spontaneous and experimental adenocarcinoma metastases with chronic indomethacin and intermittent IL-2 therapy. Int J Cancer 54:677-684, 1993. (Pubitemid 23188202)
91. Teicher BA, Holden SA, Ara G, et al: Cyclooxygenase inhibitors; In vitro and in vivo effects on antitumor alkylating agents in the EMT-6 murine mammary carcinoma. Int J Oncol 2:145-153, 1993. (Pubitemid 23043332)
92. Connolly JM, Liu X-H, Rose DP: Dietary linoleic acidstimulated human breast cancer cell growth and metastasis in nude mice and their suppression by indomethacin, a cyclooxygenase inhibitor. Nutr Cancer 25:231-240, 1996. (Pubitemid 26176126)
93. Fulton AM: Interactions of natural effector cells and prostaglandins in the control of metastasis. J Natl Cancer Inst 78:735-741, 1987. (Pubitemid 17063632)
94. Fulton AM: The role of eicosanoids in tumor metastasis. Prostaglandins Leukot Essent Fatty Acids 34:229-237, 1988.
95. Liu X-H, Rose DP: Differential expression and regulation of cyclooxygenase-1 and-2 in two human breast cancer cell lines. Cancer Res 56:5125-5127, 1996. (Pubitemid 26383023)
96. Loll PJ, Garavito RM: The isoforms of cyclooxygenase; Structure and function. Exp Opin Invest Drugs 3:1171-1180, 1994.
97. Futaki N, Takahashi S, Yokoyama M, et al: NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47:55-59, 1994. (Pubitemid 24053843)
98. Low JA, Johnson MD, Bone EA, et al: The matrix metalloproteinase inhibitor batimastat (BB - 94) retards human breast cancer solid tumor growth but not ascites formation in nude mice. Clin Cancer Res 2:1207-1214, 1996. (Pubitemid 26238453)
99. Singh Y, Morimoto J, Shikata N, et al: Inhibitory effect of the angiogenesis inhibitor O-(chloroacetylcarbamoyl) fumagillol (TNP-470) on tumor growth and metastasis of murine mammary tumor cell line (JYG-B) inoculated in female nude mice. Breast Cancer 3:105-110, 1996.